Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$677M |
| 2 |
AGN
Allergan plc
AGN
|
+$437M |
| 3 |
Qualcomm
QCOM
|
+$387M |
| 4 |
lululemon athletica
LULU
|
+$366M |
| 5 |
NVIDIA
NVDA
|
+$330M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Under Armour
UAA
|
+$1.03B |
| 2 |
Abbott
ABT
|
+$767M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$627M |
| 4 |
Meta Platforms (Facebook)
META
|
+$520M |
| 5 |
Nike
NKE
|
+$454M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 19.26% |
| 2 | Healthcare | 16.99% |
| 3 | Technology | 15.48% |
| 4 | Communication Services | 12.63% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Starbucks
SBUX
$123B
| $984M | 1.08% |
17,231,014
-4,231,763
| -20% | -$241M |
|
|
NVO
27
Novo Nordisk
NVO
$202B
| $936M | 1.03% |
34,801,602
+4,904,240
| +16% | +$134M |
|
28
American Tower
AMT
$82.1B
| $921M | 1.01% |
8,103,737
+270,233
| +3% | +$28.8M |
|
29
Monster Beverage
MNST
$91.8B
| $917M | 1.01% |
68,443,164
+5,762,184
| +9% | +$69.5M |
|
|
CXO
30
DELISTED
CONCHO RESOURCES INC.
CXO
| $910M | 1% |
7,632,992
+39,645
| +0.5% | +$4.6M |
|
31
McDonald's
MCD
$188B
| $871M | 0.96% |
7,237,227
-1,708,798
| -19% | -$214M |
|
|
ALXN
32
DELISTED
Alexion Pharmaceuticals
ALXN
| $828M | 0.91% |
7,093,395
-216,732
| -3% | -$30.8M |
|
33
TJX Companies
TJX
$149B
| $813M | 0.89% |
21,064,442
-2,133,316
| -9% | -$81.4M |
|
34
NXP Semiconductors
NXPI
$56.4B
| $742M | 0.81% |
9,469,774
+1,274,155
| +16% | +$109M |
|
35
Regeneron Pharmaceuticals
REGN
$81.8B
| $709M | 0.78% |
2,030,925
-20,934
| -1% | -$8.06M |
|
36
BioMarin Pharmaceuticals
BMRN
$12.5B
| $704M | 0.77% |
9,051,244
+301,353
| +3% | +$25.6M |
|
37
Workday
WDAY
$50.6B
| $701M | 0.77% |
9,381,572
-143,359
| -2% | -$10.9M |
|
38
Kroger
KR
$35.4B
| $687M | 0.75% |
18,669,810
-3,395,253
| -15% | -$122M |
|
|
SPLK
39
DELISTED
Splunk Inc
SPLK
| $678M | 0.74% |
12,507,744
-127,317
| -1% | -$6.72M |
|
|
40
S&P Global
SPGI
$131B
| $677M | 0.74% |
+6,307,763
| New | +$677M |
|
41
Tesla
TSLA
$1.38T
| $657M | 0.72% |
46,414,365
-7,466,220
| -14% | -$113M |
|
42
Corpay
CPAY
$26.8B
| $649M | 0.71% |
4,534,292
-59,850
| -1% | -$8.91M |
|
|
TWX
43
DELISTED
Time Warner Inc
TWX
| $642M | 0.7% |
8,726,393
-136,054
| -2% | -$10.1M |
|
44
Palo Alto Networks
PANW
$303B
| $585M | 0.64% |
28,611,318
+6,978,876
| +32% | +$162M |
|
45
GE Aerospace
GE
$355B
| $574M | 0.63% |
3,803,138
+331,357
| +10% | +$48.3M |
|
46
Illumina
ILMN
$32.6B
| $519M | 0.57% |
3,797,701
-1,753,907
| -32% | -$249M |
|
47
Halliburton
HAL
$30.1B
| $498M | 0.55% |
10,985,623
+4,695,475
| +75% | +$193M |
|
48
Biogen
BIIB
$32.3B
| $485M | 0.53% |
2,005,263
-1,460,011
| -42% | -$385M |
|
|
49
lululemon athletica
LULU
$13.7B
| $460M | 0.51% |
6,234,712
+5,510,939
| +761% | +$366M |
|
50
Morgan Stanley
MS
$337B
| $444M | 0.49% |
17,093,500
-370,049
| -2% | -$9.68M |
|
Similar funds
Jennison Associates's Q2 2016 Portfolio in Review
As of Q2 2016, Jennison Associates held 691 positions worth $91.1B, down 4.3% from $95.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jennison Associates withdrew a net $5.05B in Q2 2016, closing 61 positions and reducing 333 holdings. Its most notable exit was MCGRAW-HILL FINANCIAL INC COM, an estimated $627M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Jennison Associates opened a new position in S&P Global worth $677M.
- Jennison Associates's largest Q2 2016 buy was S&P Global: 6,307,763 shares worth $677M.
- Jennison Associates added most to Allergan plc in Q2 2016, an estimated $437M increase.
- Jennison Associates's biggest Q2 2016 reduction was Under Armour, cutting an estimated $1.03B.
- Jennison Associates fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $627M.
- Jennison Associates's ten largest holdings make up 23% of its $91.1B portfolio in Q2 2016.
- Jennison Associates opened 83 new positions and closed 61 in Q2 2016.
- Jennison Associates's portfolio value fell 4.3% quarter-over-quarter to $91.1B.
Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.